1,062 results on '"Halter J"'
Search Results
2. The impact of the catalyst layer structure on phosphoric acid migration in HT-PEFC – An operando X-ray tomographic microscopy study
3. Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation
4. The influence of phosphoric acid migration on the performance of high temperature polymer electrolyte fuel cells
5. P29 - DYSLIPIDEMIA AFTER INTENSIVE IMMUNOSUPPRESSIVE THERAPY VERSUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA: A SINGLE-CENTER EXPERIENCE
6. Schlauchmagenbildung in der Behandlung der morbiden Adipositas
7. Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation
8. Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study
9. Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation—the Swiss Transplant Cohort Study
10. Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic
11. Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study
12. Iron deficiency and thrombocytosis
13. Numerical impairment of nestin+ bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML
14. Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation
15. Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation
16. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
17. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
18. Pre-emptive diagnosis and treatment of fungal infections—evaluation of a single-centre policy
19. Decomposition of spinal cord evoked potentials into propagating and stationary components
20. An atlas of human spinal cord evoked potentials
21. Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study
22. Clinical guide to fertility preservation in hematopoietic cell transplant recipients
23. PBSC collection from family donors in Japan: a prospective survey
24. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT
25. bleedHD: a Tool for Assessment of Bleeding and Graftversus-Host Disease in Hemato-oncological Patients: AB37
26. Linking MED-A-data to an external database: the GVHD-registry project: P751
27. Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT
28. Combination therapy for multidrug-resistant cytomegalovirus disease
29. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) directly from positive blood culture flasks allows rapid identification of bloodstream infections in immunosuppressed hosts
30. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
31. Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients
32. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT
33. GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM
34. Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)
35. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation
36. Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation
37. Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD
38. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
39. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
40. Tumor incidence in related hematopoietic stem cell donors
41. Schlauchmagenbildung in der Behandlung der morbiden Adipositas: Studienergebnisse und erste Erfahrungen mit der transvaginalen Hybrid-NOTES-Technik
42. Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT
43. High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML
44. Graft source determines human hematopoietic progenitor distribution pattern within the CD34+ compartment
45. Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
46. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach
47. Unrelated hematopoietic stem cell donors as research subjects
48. Family donor care management: principles and recommendations
49. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
50. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.